Chemicals
18 companies · $136B combined revenue · $6.7B operating profit
The typical US-listed chemicals company grew revenue -1.3% and earnings -55.9% in its latest year, at a 6.2% operating margin, and 2 of 17 earn a return on capital above 15%. Figures from each company's latest annual filing with the SEC, refreshed daily.
Growth engines: the 4 Cylinders
All four working: 0% of companiesA company's earnings per share can grow in only four ways: more sales, profits growing faster than sales (operating leverage), wider margins, and less debt. Each bar is the share of companies where that engine worked in their latest year.
- Sales growth · Revenue up 10% or more11%
- Operating leverage · Operating income growing faster than a growing revenue23%
- Margin expansion · Operating margin up 1 point or more12%
- Debt reduction · Debt down 5% or more, or net cash27%
Combined revenue · 18 companies reporting in US dollars
Combined operating margin
All 18 companies
| Median | – | -1.3% | -55.9% | 6.2% | 2.7% | 0.79x |
| LINLINDE | $34.0B | 3%▲ | 5.1%▲ | 26.3%▲ | 12.5%▲ | 0.59x▲ |
| APDAir Products & Chemicals | $12.0B | -0.5%▲ | -110%▼ | -7.3%▼ | -2.4%▼ | 1.18x▼ |
| DOWDow | $40.0B | -7%▼ | -303%▼ | -4.1%▼ | -3.3%▼ | 1.12x▼ |
| DDDuPont de Nemours | $6.8B | 1.9%▲ | -211%▼ | 7.5%▲ | 2.7% | 0.23x▲ |
| ALBAlbemarle | $5.1B | -4.4%▼ | – | -7.1%▼ | -2.5%▼ | 0.33x▲ |
| SOLSSolstice Advanced Materials | $3.9B | 3.1%▲ | -60.1%▼ | 17.4%▲ | 17%▲ | 1.40x▼ |
| EMNEastman Chemical | $8.8B | -6.7%▼ | -47.6%▲ | – | – | 0.80x▼ |
| HXLHexcel | $1.9B | -0.5%▲ | -17.2%▲ | 9.1%▲ | 7.2%▲ | 0.79x |
| BCPCBalchem | $1.0B | 8.8%▲ | 20.5%▲ | 20.2%▲ | 13.9%▲ | – |
| CECelanese | $9.5B | -7.1%▼ | – | -8.2%▼ | -4.4%▼ | 3.41x▼ |
| PRMPerimeter Solutions | $653M | 16.4%▲ | – | -30.8%▼ | -8.1%▼ | 0.59x▲ |
| AVNTAvient | $3.3B | 0.6%▲ | -51.7%▲ | 6.2% | 3.9%▲ | 0.81x▼ |
| ASHAshland | $1.8B | -13.7%▼ | -600%▼ | -42.5%▼ | -18.5%▼ | 0.73x▲ |
| HWKNHawkins | $1.1B | 11.2%▲ | -3.3%▲ | 11.2%▲ | 13.8%▲ | 0.46x▲ |
| ROGRogers | $811M | -2.3%▼ | -337%▼ | -5.6%▼ | -3.5%▼ | – |
| NGVTIngevity | $1.2B | -2.7%▼ | – | 35.9%▲ | 32%▲ | 41x▼ |
| IOSPInnospec | $1.8B | -3.7%▼ | 228%▲ | 7.3%▲ | 8.8%▲ | – |
| MTXMinerals Technologies | $2.1B | -2.2%▼ | -111%▼ | 2.3%▼ | 1.6%▼ | 0.56x▲ |
▲ better than the median, ▼ worse. n/a: the ratio doesn't apply to that kind of business (e.g. a bank's operating margin). Sort by any column. Figures from each company's latest 10-K (or 20-F/40-F).